2 1 Shi Ji Jing Ji Bao Dao·2025-06-23 11:59Group 1 - The "brain-computer interface" (BCI) concept has gained significant attention in the A-share market, with stocks like Seer Medical and Sanbo Brain Science experiencing notable price increases [1][3] - Investors are actively inquiring about companies' involvement in BCI technology, indicating a high level of market interest and potential investment opportunities [3] - Companies such as Chengyi Tong have established dual-track strategies in both invasive and non-invasive BCI technologies, with plans to integrate existing rehabilitation devices with BCI technology [3] Group 2 - The BCI industry is primarily focused on medical applications, but future growth is expected in education, gaming, and smart home sectors, driven by advancements in artificial intelligence and sensor technology [2] - Sanbo Brain Science is utilizing various diagnostic and treatment methods for neurological diseases, and is actively recruiting participants for BCI trials to assess the safety and efficacy of their technology [4] - Other companies like Chengdu Huayi and Nanjing Panda are developing hardware solutions and interactive display terminals for BCI applications, while Weisi Medical has accumulated patents in non-invasive BCI electrode technology [5] Group 3 - The BCI technology landscape is categorized into invasive, semi-invasive, and non-invasive methods, each with distinct advantages in signal quality and safety [7] - The industry value chain includes upstream suppliers of EEG devices and algorithms, midstream BCI platforms, and downstream applications in entertainment, education, and healthcare [7] - Companies like Yike Technology are collaborating with cloud computing firms to enhance their BCI clinical trials through advanced data processing and storage solutions [8]